Evidence map›Paper›PMID 33941693›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2021

Dysregulation of Amphiregulin stimulates the pathogenesis of cystic lymphangioma.

Naofumi Yoshida, Seiji Yamamoto, Takeru Hamashima, Noriko Okuno, Naruho Okita, Shinjiro Horikawa, Masao Hayashi, Thanh Chung Dang, Quang Linh Nguyen, Koichi Nishiyama and 7 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Lymphangioma Cavernosum with a Rare Location.Journal of clinical medicine · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 6 institutions in 2 countries.

Naofumi YoshidaDepartment of Pathology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama 930-0194, Japan.
Seiji YamamotoDepartment of Pathology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama 930-0194, Japan; seiyama@med.u-toyama.ac.jp sasahara@med.u-toyama.ac.jp.
Takeru HamashimaDepartment of Pathology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama 930-0194, Japan.
Noriko OkunoDepartment of Pathology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama 930-0194, Japan.
Naruho OkitaDepartment of Pathology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama 930-0194, Japan.
Shinjiro HorikawaIntensive Care Unit, Toyama Prefectural Central Hospital, Toyama 930-8550, Japan.
Masao HayashiDepartment of Pathology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama 930-0194, Japan.
Thanh Chung DangDepartment of Pathology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama 930-0194, Japan.ORCID 0000-0003-2376-1665
Quang Linh NguyenDepartment of Pathology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama 930-0194, Japan.
Koichi NishiyamaInternational Research Center for Medical Sciences, Kumamoto University, 860-0811 Kumamoto, Japan.
Teruhiko MakinoDepartment of Dermatology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama 930-0194, Japan.
Yoko IshiiDepartment of Health Science, Faculty of Health and Human Development, The University of Nagano, 380-8525 Nagano, Japan.
Kei TomiharaDepartment of Oral and Maxillofacial Surgery, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama 930-0194, Japan.
Tadamichi ShimizuDepartment of Dermatology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama 930-0194, Japan.ORCID 0000-0002-3231-0279
Masabumi ShibuyaInstitute of Physiology and Medicine, Jobu University, Gunma 370-1393, Japan.
Makoto NoguchiDepartment of Oral and Maxillofacial Surgery, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama 930-0194, Japan.
Masakiyo SasaharaDepartment of Pathology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama 930-0194, Japan; seiyama@med.u-toyama.ac.jp sasahara@med.u-toyama.ac.jp.ORCID 0000-0001-6982-9077
University of Toyama · JPJobu University · JPNagano University of Health and Medicine · JPToyama Prefectural Central Hospital · JPUniversity of Miyazaki · JPVietnam Military Medical University · VN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Along with blood vessels, lymphatic vessels play an important role in the circulation of body fluid and recruitment of immune cells. Postnatal lymphangiogenesis commonly occurs from preexisting lymphatic vessels by sprouting, which is induced by lymphangiogenic factors such as vascular endothelial growth factor C (VEGF-C). However, the key signals and cell types that stimulate pathological lymphangiogenesis, such as human cystic lymphangioma, are less well known. Here, we found that mouse dermal fibroblasts that infiltrate to sponges subcutaneously implanted express VEGF-D and sushi, Von Willebrand factor type A, EGF, and pentraxin domain containing 1 (SVEP1) in response to PDGFRβ signal. In vitro,

Indexed as

AmphiregulinAnimalsCell ProliferationEndothelial CellsFemaleFibroblastsHumansLymphangiogenesisLymphangioma, CysticLymphatic VesselsMaleMiceMice, KnockoutReceptor, Platelet-Derived Growth Factor betaVascular Endothelial Growth Factor CVascular Endothelial Growth Factor DAmphiregulinAREG protein, humanAreg protein, mouseReceptor, Platelet-Derived Growth Factor betaVascular Endothelial Growth Factor CVascular Endothelial Growth Factor DVegfd protein, mouseAmphiregulincystic lymphangiomalymphangiogeneispathogenesisPDGFRβ CKO

Identifiers

PMID33941693
PMCPMC8126796
OpenAlexW3159952614

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.